Primary Site >> Colorectal Cancer

Gene >> PARP2

  • 2012
  • 2015
  • 2018
Ref: The combination of olaparib and camptothecin for effective radiosensitization.
PMID: 22524618
Ref: Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status.
PMID: 25685067
Ref: Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1.
PMID: 30046848